drug summary · 3 NDC codes
OxyContin 60 mg/1
oxycodone hydrochloride
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | oxycodone hydrochloride |
|---|---|
| active ingredients | OXYCODONE HYDROCHLORIDE |
| dosage form | TABLET, FILM COATED, EXTENDED RELEASE |
| route | ORAL |
| strength | 60 mg/1 |
| marketing status | NDA |
| DEA schedule | CII |
| application number | NDA022272 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | Knoa Pharma LLC |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Full Opioid Agonists [MoA]; Opioid Agonist [EPC] |
NDC codes
3 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 59011-460 | — |
| 59011046010 | — |
| 59011046020 | — |
Other oxycodone hydrochloride products
6 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- OxyContin 10 mg/1TABLET, FILM COATED, EXTENDED RELEASE · Knoa Pharma LLC
- OxyContin 15 mg/1TABLET, FILM COATED, EXTENDED RELEASE · Knoa Pharma LLC
- OxyContin 20 mg/1TABLET, FILM COATED, EXTENDED RELEASE · Knoa Pharma LLC
- OxyContin 30 mg/1TABLET, FILM COATED, EXTENDED RELEASE · Knoa Pharma LLC
- OxyContin 40 mg/1TABLET, FILM COATED, EXTENDED RELEASE · Knoa Pharma LLC
- OxyContin 80 mg/1TABLET, FILM COATED, EXTENDED RELEASE · Knoa Pharma LLC
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.